TG THERAPEUTICS, INC. (13)

Browse by Contract Category

Contracts

Description of Securities of TG Therapeutics, Inc (Filed With SEC on March 1, 2021)
Underwriting Agreement, dated December 14, 2020, by and among TG Therapeutics, Inc. and J.P. Morgan Securities LLC, Goldman Sachs & Co. LLC, Evercore Group L.L.C. and Cantor... (Filed With SEC on December 16, 2020)
Amendment to TG Therapeutics, Inc. Amended and Restated 2012 Incentive Plan (Filed With SEC on June 24, 2020)
At Market Issuance Sales Agreement, among the Company and Jefferies LLC, Cantor Fitzgerald & Co. and B. Riley FBR, Inc., dated March 20, 2020 (Filed With SEC on March 20, 2020)
Underwriting Agreement, dated May 14, 2020, by and among TG Therapeutics, Inc. and J.P. Morgan Securities LLC, Jefferies LLC, Evercore Group L.L.C. and Cantor Fitzgerald & Co., as... (Filed With SEC on May 18, 2020)
Description of Securities of TG Therapeutics, Inc (Filed With SEC on March 2, 2020)
Amended and Restated Collaboration Agreement by and between TG Therapeutics, Inc. and Checkpoint Therapeutics, Inc., dated June 19, 2019 (Filed With SEC on August 9, 2019)
Master Services Agreement between Samsung Biologics Co., Ltd. and TG Therapeutics, Inc., effective February 21, 2018 (Filed With SEC on August 9, 2019)
Underwriting Agreement, dated March 1, 2019, by and between TG Therapeutics, Inc. and Cantor Fitzgerald & Co (Filed With SEC on March 5, 2019)
Warrant Agreement, dated February 28, 2019, by and between TG Therapeutics, Inc. and Hercules Capital, Inc (Filed With SEC on March 5, 2019)
Warrant Agreement, dated February 28, 2019, by and between TG Therapeutics, Inc. and Hercules Technology III, L.P (Filed With SEC on March 5, 2019)
Loan and Security Agreement, dated February 28, 2019, by and among TG Therapeutics, Inc., TG Biologics, Inc. and Hercules Capital, Inc (Filed With SEC on March 5, 2019)
Master Services Agreement, effective February 21, 2018 (Filed With SEC on March 1, 2019)